Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Mallinckrodt
Colorcon
Express Scripts
Dow

Last Updated: May 28, 2022

CLINICAL TRIALS PROFILE FOR DESMOPRESSIN ACETATE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Desmopressin Acetate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00111215 ↗ Treatment and Management of Women With Bleeding Disorders Completed Centers for Disease Control and Prevention N/A 2001-01-01 The purpose of the study is to determine whether oral contraceptives, desmopressin acetate, and/or tranexamic acid are effective in the treatment of women with menorrhagia who are diagnosed with a bleeding disorder.
NCT00477490 ↗ Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia Completed Ferring Pharmaceuticals Phase 3 2007-05-01 The purpose of this study is to investigate the efficacy and safety of several doses of the melt formulation of desmopressin in a broad population of adult patients with nocturia.
NCT00835211 ↗ Desmopressin Acetate 0.2 mg Tablets, Fasting Completed Teva Pharmaceuticals USA Phase 1 2003-07-01 The objective of this study was to compare the single-dose relative bioavailability of TEVA and Aventis Pharmaceuticals (DDAVP┬«) 0.2 mg desmopressin acetate tablets following a 0.8 mg dose under fasting conditions.
NCT01982760 ↗ DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty Unknown status University Hospitals Cleveland Medical Center Phase 2 2013-12-01 This is study looking at the use of a medication, Desmopressin acetate (DDAVP), to reduce bleeding, swelling, and bruising in patients undergoing cosmetic nose surgery. DDAVP is a drug used in patients with bleeding disorders. It works by activating molecules in the blood stream called platelets that promote clotting. In the study, participants who are have cosmetic nose surgery (rhinoplasty) will be randomly assigned to receive or not receive medication. Photographs taken before and shortly after surgery will be evaluated for the amount of bruising and swelling. Patients with heart, lung, kidney, or liver problems are not eligible to participate.
NCT02538302 ↗ Minirin Versus Oxybutynin for Nocturnal Enuresis in Children Completed Hormozgan University of Medical Sciences Phase 3 2013-07-01 Nocturnal enuresis is among the most common disorders in children. The aim of current study was to compare the efficacy and safety of Minirin and oxybutynin for treatment of nocturnal enuresis in children in Bandar Abbas in 2014.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Desmopressin Acetate

Condition Name

Condition Name for Desmopressin Acetate
Intervention Trials
Menorrhagia 1
Metastatic Cancer 1
Mild Hemophilia A Without Inhibitor 1
Nocturia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Desmopressin Acetate
Intervention Trials
Urinary Incontinence 2
Nocturnal Enuresis 2
Enuresis 2
Hemophilia A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Desmopressin Acetate

Trials by Country

Trials by Country for Desmopressin Acetate
Location Trials
United States 34
Canada 4
Egypt 2
China 1
Iran, Islamic Republic of 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Desmopressin Acetate
Location Trials
Georgia 2
North Carolina 2
New York 2
New Jersey 2
Ohio 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Desmopressin Acetate

Clinical Trial Phase

Clinical Trial Phase for Desmopressin Acetate
Clinical Trial Phase Trials
Phase 4 2
Phase 3 2
Phase 2 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Desmopressin Acetate
Clinical Trial Phase Trials
Completed 4
Recruiting 3
Unknown status 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Desmopressin Acetate

Sponsor Name

Sponsor Name for Desmopressin Acetate
Sponsor Trials
Centers for Disease Control and Prevention 1
Ferring Pharmaceuticals 1
Teva Pharmaceuticals USA 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Desmopressin Acetate
Sponsor Trials
Other 7
Industry 3
U.S. Fed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Mallinckrodt
Merck
Medtronic
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.